Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19322519

Download in:

View as

General Info

PMID
19322519